NEW YORK (GenomeWeb News) – Swiss firm Lonza said today that it has acquired cell research products firm amaxa for an undisclosed sum.
Lonza expects the acquisition to strengthen the cell discovery business of its Lonza Bioscience division, which supplies primary cells and serves a similar customer base to that of amaxa. Cologne, Germany-based amaxa’s Nucleofection technology is used to transfer DNA or RNA into cells that are considered difficult to transfect.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.